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Abstract: The Clostridium perfringens necrotic enteritis B-like toxin (NetB) is a recently 
discovered member of the β-barrel pore-forming toxin family and is produced by a subset 
of avian C. perfringens type A strains. NetB is cytotoxic for avian cells and is associated 
with avian necrotic enteritis. This review examines the current state of knowledge of NetB: 
its  role  in  pathogenesis,  its  distribution  and  expression  in  C.  perfringens  and  its 
vaccine potential. 
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1. Introduction  
C. perfringens is a Gram-positive anaerobe and is ubiquitous in the environment, being found in 
soil, in decaying organic matter, and as a member of the normal intestinal flora of many humans and 
animals  [1].  Specific  C.  perfringens  toxin  types  are  associated  with  particular  human  and  animal 
diseases,  indicating  that  variations  in  toxin  production  influence  the  virulence  properties  of 
C. perfringens isolates [2–4]. C. perfringens strains are typed by the production of four major toxins 
(ʱ, β, ε, ι) [3]. Type A strains are the most widespread and are commonly found in the intestines of 
warm blooded animals and in the environment. Type A strains cause gas gangrene in humans and 
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enteric diseases in humans and animals [5–8]. Type C strains cause mucosal necrosis of the small 
intestine in humans and pigs, while type B and C strains cause enteric disease in small ruminants [5].  
Necrotic enteritis in poultry is a global problem and it has been estimated that the disease costs the 
international poultry industry in excess of $US 2 billion per year in production losses and control 
measures [9–11]. Avian necrotic enteritis is an enteric disease that is characterized by necrotic lesions 
in the small intestinal mucosa [12]. The disease can be divided into two forms, clinical and subclinical. 
The clinical signs of acute necrotic enteritis can be seen from about two weeks of age and include 
marked depression, dehydration, apathy, diarrhea, ruffled feathers, and decreased feed consumption 
[13–16]. Birds showing clinical signs normally die within a few hours, with mortality rates reaching up 
to 1% per day [13]. The diagnosis of subclinical necrotic enteritis is based on a decrease in the feed 
conversion ratio and the detection of gross necrotic lesions in the small intestinal mucosa (Figure 1) 
followed by bacteriologic analysis and genotyping of isolates [12]. Macroscopic lesions can be seen in 
the small intestine and can sometimes be found in other organs, such as the liver, kidney and cecum 
[17]. In an affected bird, the small intestine can become enlarged due to gas accumulation and the wall 
of the intestine can become thin and delicate [18]. Subclinical necrotic enteritis is observed at varying 
ages  of  birds,  but  most  commonly  it  is  first  detected  in  birds  at  21  to  23  days  of  age  [9].  The 
subclinical form of the disease is not only of significance to the animals’ welfare, but also to the 
producer through lost productivity and the added cost of disease intervention.  
Figure 1. Gross pathology of the small intestine of infected birds. (a–c) are three examples 
of  necrotic  enteritis  lesions  in  the  small  intestines  of  broiler  chickens  challenged  with 
C. perfringens.  
a.
b.
c.
 
All C. perfringens strains produce  -toxin, a major extracellular toxin that has been shown to be 
essential for human myonecrosis [19]. It was previously thought [14,20,21] that  -toxin was the major 
toxin involved in necrotic enteritis, but we have shown that an  -toxin null mutant is still virulent in a Toxins 2010, 2  
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chicken necrotic enteritis disease model  [22]. This result led us to postulate that virulent necrotic 
enteritis strains produce other toxins that are responsible for the pathogenesis of disease. Recently, we 
identified a new toxin, NetB, in avian C. perfringens type A strains [23]. NetB is a key virulence factor 
in C. perfringens strains that cause avian necrotic enteritis. Here we review our current knowledge of 
the biology, distribution, regulation, role in disease, and potential vaccine applications of this new toxin. 
2. Identification and Analysis of NetB 
NetB was discovered in an Australian strain of C. perfringens type A that was isolated from a 
chicken with necrotic enteritis [23]. Earlier work, aimed at defining the role of  -toxin, had indicated 
that secreted products from C. perfringens were able to cause lesions typical of necrotic enteritis in 
chickens [20]. Based on these results, and our finding that  -toxin was not required for disease, we 
tested culture supernatant from our  -toxin mutant against various mammalian and chicken cell lines 
to determine whether any novel cytotoxic factors could be identified. One cell line, LMH (ATCC 
CRL-2117), was found to be sensitive to an unknown protein in the supernatant. Subsequently, LMH 
cytotoxicity was used to follow this toxic activity during the purification process. The  N-terminal 
sequence of the purified protein was determined and used to search the genome sequence of the parent 
C. perfringens strain, EHE-NE18. A novel toxin gene that encoded a 323 amino acid protein, including 
a  30  amino  acid  secretion  signal  sequence,  was  identified.  Since  this  protein  has  similarity  to 
C. perfringens β-toxin (38% identity) it was designated necrotic enteritis toxin, B-like (NetB) [23]. In 
addition  to  β-toxin,  NetB  has  sequence  identity  to  C.  perfringens  δ-toxin  (40%  identity), 
Staphylococcus aureus ʱ-hemolysin (30% identity), the A, B and C components of S. aureus γ-toxin 
(25%, 22% and 23% identity, respectively), the S and F components of S. aureus leukocidin (25% and 
22% identity, respectively) and to Bacillus cereus cytotoxin K (27% identity). Alignment of these 
sequences  (Figure  2)  reveals  that  only  14  amino  acids  are  identical  in  these  proteins  and  that 
50 residues are conservatively substituted. The areas of similarity are dispersed throughout the toxin, 
with the weakest similarity in the N-terminal region.  
At least 35% of the known protein toxins produced by bacteria belong to the pore-forming group of 
membrane damaging toxins [24]. These toxins form pores that disrupt the phospholipid membrane 
bilayer of both human and animal cells, causing an influx of ions (i.e., Na
+, Cl
−, Ca
2+, etc.) that may 
lead to osmotic cell lysis. Many of these toxins have been demonstrated to contribute to the virulence 
of bacteria and to play a key role in the pathogenesis of human and animal infections [25–31]. NetB 
has many of the conserved residues found in pore-forming toxins of the S. aureus toxin family [32]. 
For example, the  -hemolysin, or  -toxin, from S. aureus is a secreted, self-assembling, pore-forming 
toxin [33]. It has a signal peptide of 26 amino acids and in its mature form consists of a 293 amino acid 
polypeptide with a calculated molecular size of 33 kDa  [34,35]. β-toxin also is a member of this 
pore-forming  family  and  is  a  lethal  extracellular  toxin  produced  by  C.  perfringens  type  B  and  C 
strains [36].  β-toxin  is  secreted  in  late  exponential  growth  phase  and  is  extremely  susceptible  to 
proteases and to heat [37,38]. Located on a plasmid [39], the β-toxin structural gene, cpb, encodes a 
336 amino acid polypeptide that includes a 27-amino acid signal sequence, which is cleaved to form 
the mature β-toxin protein (34 kDa) [40].  Toxins 2010, 2  
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Figure 2. ClustalW alignment of NetB. ClustalW alignment of the toxins C. perfringens 
NetB  (EU143239),  C.  perfringens  β-toxin  (Cpb,  AAA23284.1),  C.  perfringens  δ-toxin 
(Cpd, ACF93710.1), B. cereus hemolysin II (Hly-II, NP_833256.1), cytotoxin K (CytK, 
CAC08441.1) and S. aureus ʱ-toxin (Hla, NP_371687.1), γ-toxin A (HlgA, P0A074.1), 
B (HlgB, P0A077.1), C (HlgC, Q07227.1), Leukocidin S (LukS, NP_058465.1), F (LukF, 
NP_058466.1).  Identical  residues  (*),  conservative  amino  acid  substitutions  (:)  and  
semi-conservative amino acid  substitutions  (.) are shown below the  aligned sequences. 
Residues highlighted in bold represent the known or predicted signal peptide sequence of 
each protein and residue numbers begin following the signal peptide sequence. Red boxes 
indicate those residues that are known to be involved in the activity of at least one of these 
proteins, as discussed in the text. To compact the figure the Hly-II sequence was shortened.  
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Figure 2. Cont. 
 
Site-directed mutagenesis has been used to characterize many amino acids critical for function in 
C. perfringens β-toxin and S. aureus  -toxin [41,42] and NetB contains many of these key residues 
including  R200  (R212  from  β-toxin).  The  corresponding  residue  in  S.  aureus  -toxin  (R200)  is 
important for binding and oligomerization of the protein as well as for hemolysis [43]. Mutation of the 
β-toxin residue Y203 (Y191 in NetB) to phenylalanine resulted in a 2.5-fold increase in the LD50. The 
corresponding  residue  in  S.  aureus  -toxin  (Y191)  is  located  at  the  predicted  membrane  binding 
surface  of  the  protein  [44].  Mutation  of  the  β-toxin  residue  D167  (D156  in  NetB)  resulted  in  a 
complete  loss  of  functional  protein  expression,  suggesting  that  this  region  participates  in  crucial 
protomer-protomer interactions as well as being important for conformational rearrangements involved 
in multimer formation in the membrane bound form [44].  
Since  NetB  had  many  of  the  residues  essential  for  β-toxin  and  S.  aureus  -toxin  function  we 
postulated that NetB was likely to be a pore-forming toxin. Subsequent studies demonstrated that NetB 
was found to be cytotoxic to LMH cells but not to other chicken cell lines such as DF1 and HD11 cells 
or the mammalian Vero cell line [23]. NetB (2.5 ng/µL) causes significant cell rounding and cell lysis 
in as little as 30 min. Incubation with PEG 1000 and PEG 1500 blocked these morphological changes 
and LDH release from the cells, indicating that NetB most likely forms plasma membrane pores with 
an estimated pore diameter of 1.6 to 1.8 nm [23]. This NetB pore diameter is slightly larger than the 
pore size predicted for  -toxin (1.36–1.6 nm) in HL 60 cells [45].  -toxin has been shown to induce 
significant host cell swelling without blebbing, cell lysis, and the release of K
+ from human leukemia 
cells (HL 60) [45]. Incubation of HL 60 cells with  -toxin resulted in the formation of toxin complexes 
of about 191 kDa (hexamer) and 228 kDa (heptamer). The 228 kDa complex was observed up to 
30 min after incubation with the cells, while the 191 kDa complex remained after 60 min.  
-toxin is another C. perfringens pore-forming toxin that has sequence identity with NetB [46]. This 
toxin is a hemolysin released by several C. perfringens type C and possibly type B strains [47]. It is 
cytotoxic for various cell types such as rabbit macrophages, human monocytes, and blood platelets Toxins 2010, 2  
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from  goats,  rabbits,  humans  and  guinea  pigs  [46,48–50].  The  toxin  forms  pores  in  artificial  lipid 
bilayers similar to β-toxin, however, these toxins do not share a similar receptor since δ-toxin binds to 
gangliosides (GM2) unlike β-toxin [46]. Some C. perfringens type B and C strains that are involved in 
necrotic enteritis in various animal species, mainly piglets, and also in humans, produce δ-toxin, but no 
direct link between this toxin and disease has been demonstrated.  
The  essential  role  of  NetB  in  disease  was  determined  by  constructing  a  structural  gene  (netB) 
mutant in strain EHE-NE18 and assessing its virulence in a chicken disease model [23]. Virulence 
testing of an isogenic series of strains  consisting of the wild type,  netB mutant, and netB mutant 
complemented with the wild-type netB gene, revealed that the development of necrotic enteritis in 
chickens was dependent on the ability to produce functional NetB toxin. This result parallels studies on 
the  -toxin of S. aureus, which in a mouse model of S. aureus pneumonia has been shown to be an 
important virulence factor of methicillin-resistant S. aureus (MRSA) [51]. S. aureus  -toxin negative 
mutants were found to be 10-fold less virulent than ʱ-toxin producing strains. Similar results have been 
obtained for  -toxin and it has been shown to be essential for hemorrhagic necrotizing enteritis in 
rabbit ileal loops [52]. In that study, mutations in the β-toxin structural gene, cpb, were constructed and 
shown to be avirulent in the ileal loop model. Complementation of a cpb mutant restored its ability to 
produce  -toxin and restored virulence in the loop model. In addition, highly purified  -toxin was able 
to reproduce intestinal damage that was similar to infection with the wild-type C. perfringens strain. 
Both NetB and  -toxin act in the gastrointestinal tract of animals, however,  -toxin has also been 
suggested to cause toxemia after absorption of the toxin from the intestines into the circulation [53,54]. 
However,  no  experiments  aimed  at  determining  if  NetB  enters  the  circulatory  system  of  infected 
chickens have been reported.  
Recent studies have revealed that in several necrotic enteritis isolates the netB gene is part of a large 
potential  pathogenicity  locus  [55].  Comparative  analysis  of  genomic  sequences  from  seven 
independent  disease-causing  C.  perfringens  isolates  and  a  range  of  non-necrotic  enteritis  strains 
showed that the netB gene is located on a 42 kilobase (kb) locus (NELoc-1). In addition, Southern 
blots suggest that the netB gene is located on an approximately 85 kb plasmid. From the genomic 
analysis, two other smaller loci (NELoc-2 and NELoc-3) also appear to be associated with necrotic 
enteritis strains. The identification of these pathogenicity loci may lead to the discovery of additional 
virulence factors that are involved in the pathogenesis of disease.  
3. Strain Distribution 
C. perfringens is commonly present within the normal flora of the gastrointestinal tract of chickens. 
However, under conditions that are still not fully understood, birds can develop necrotic enteritis, with 
disease  progression  correlating  with  the  proliferation  of  C.  perfringens  cells  in  the  intestine.  To 
understand what types of C. perfringens isolates are involved in this changing ecological balance, 
several studies have examined the clonal variation of C. perfringens isolates. Epidemiological studies 
of strains from varied  geographical locations have shown that healthy chickens harbor a range of 
genotypes, as determined by PCR, PFGE and  MLST studies, while isolates from birds present in 
individual flocks that have acute necrotic enteritis tend to have only one genotype of C. perfringens 
[56–64]. In contrast to these findings, which involved acute disease outbreaks, in one study birds from Toxins 2010, 2  
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a single flock that displayed mild necrotic enteritis symptoms were found to harbor a genetically varied 
range of isolates [64].  
Since the discovery of NetB [23] several studies have screened for the presence of the netB gene 
within a wide variety of  C.  perfringens  strains.  Initial screening  of  a  range of Australian poultry 
necrotic enteritis isolates found that the majority (77%) were netB positive [23]. In addition, in vitro 
expression analysis confirmed that all of the netB positive strains that were tested produced the NetB 
protein.  Furthermore,  several  non-necrotic  enteritis  strains  were  analyzed  and  found  to  be  netB 
negative. These netB-negative strains included representatives of each of the toxin types A to E, which 
had been isolated from cattle, sheep, pigs and humans. Subsequent studies that screened for the netB 
gene  in  strains  of  C.  perfringens  from  other  geographical  regions  showed  that  there  is  a  good 
correlation between the isolation of C. perfringens from a diseased bird and the presence of the netB 
gene [59,64–66]. In combination, 60 to 90% of the strains isolated from birds with necrotic enteritis 
were found to have the netB gene. Chalmers et al. [59], studied Canadian C. perfringens strains, and 
found that the netB gene was detected only in isolates associated with necrotic enteritis outbreaks; it 
was not identified in isolates from healthy birds. Analysis of isolates from the USA showed that the 
netB gene was in 60% of necrotic enteritis strains (7/12) [65]. Examination of a single broiler flock 
from Sweden found that more than 90% of all isolates from necrotic enteritis-affected poultry were 
netB positive [64]. The same trend was found in an extended study of strains from three continents 
[66], where 70% of isolates from necrotic enteritis affected birds were netB positive. Together, these 
results  suggest  that  the  NetB  toxin  is  necrotic  enteritis  specific,  since  the  netB  gene  is  strongly 
associated with necrotic enteritis-derived strains from poultry. Until recently, the netB gene had only 
been found in poultry related strains, however, the first non-poultry based recovery of a netB positive 
C. perfringens isolate has now been reported. A netB positive strain was isolated from liver abscesses 
from a cow that had died with gastrointestinal disease, although this particular C. perfringens strain 
was not considered to be the causative agent [65]. In a chicken disease model, this bovine isolate has 
also been shown to cause lesions characteristic of avian necrotic enteritis [67].  
Not all C. perfringens strains isolated from birds that clearly displayed signs of necrotic enteritis 
were netB positive. In nearly every study, there was a minor fraction of netB negative isolates from 
diseased birds [23,59,64–66,68]. In one particular study [65] a netB negative isolate was recovered 
from a chicken displaying clear signs of necrotic enteritis. To show that there were no sampling errors 
involved, 25 isolates were recovered from different lesion areas of the same chicken; they were all 
netB negative. These results imply that although there is a clear association between production of 
NetB toxin and development of the pathology of necrotic enteritis, there may be other—yet to be 
determined—virulence factors that are produced by these netB negative disease-producing strains. By 
contrast, several netB negative strains isolated from lesion material have been tested for their ability to 
cause disease in necrotic enteritis animal models and found to induce little or no signs of disease 
[66,67,69]. Importantly, one  netB negative strain, JGS4104,  induced a  significant  level  of disease 
(43.8%) [69], again suggesting that there may be other factors, besides NetB, that allow C. perfringens 
type A to cause tissue damage similar to necrotic enteritis. In this study the strains re-isolated from the 
diseased birds were analyzed by PFGE. Given the recent demonstration that the netB structural gene is 
plasmid borne [55], it is unclear if it is possible using PFGE to detect a difference between a strain that 
remains  netB  negative  and  one  that  has  obtained  the  NELoc-1-containing  plasmid.  Clearly,  more Toxins 2010, 2  
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research needs to be done to test and assess the virulence of additional isolates of different origins and 
genotypes in the chicken disease model.  
Whilst the netB gene has been found mainly in association with poultry with necrotic enteritis, it 
has also been identified in C. perfringens strains from healthy birds. In one study [65], 8.8% of isolates 
(7/80) from normal chickens were netB positive. In another study, analysis of strains from a single 
broiler flock that contained birds affected with mild necrotic enteritis, revealed that 25% of the isolates 
from apparently healthy birds were netB positive [64]. Nowell et al. 2009 [70] used an enrichment 
process to recover 88 C. perfringens isolates from retail grocery chicken samples and found that the 
netB gene could be detected in 21% of these isolates. Therefore, as previously suggested, it appears 
that the presence of a netB positive strain is not sufficient to cause disease, predisposing conditions are 
required. Analysis of strains from various Danish broiler flocks found that 61% of isolates recovered 
from healthy birds were netB positive [68]. This was markedly different from the results obtained from 
previous studies on strains from healthy birds [59,65,66]. When these Danish netB positive isolates 
were tested for in vitro expression of the NetB protein, a marked difference in the NetB expression 
rates was observed [68]. The NetB protein was found in 12 out of 13 of the isolates from the necrotic 
enteritis diseased birds. By comparison, only four out of 14 PCR positive isolates from healthy birds 
produced detectable NetB protein. These results are in stark contrast to our own findings, where every 
strain that carries netB produces NetB protein. It would be interesting to test these NetB producing and 
NetB non-producing netB positive strains isolated from healthy birds for NetB expression in vivo and 
to determine if they are equally capable of disease production.  
4. Regulation of NetB Production and NetB Sequence Variation 
Expression of the netB gene is regulated by VirSR, the global regulator of C. perfringens toxin 
production [71]. In the human gas gangrene-causing C. perfringens type A strain 13, the VirSR system 
is part of a complex signal transduction pathway that directly regulates the production of extracellular 
toxins and enzymes such as perfringolysin O and  -clostripain and regulates the expression of  -toxin, 
collagenase  and  many  housekeeping  genes  by  controlling  the  expression  of  the  regulatory  RNA 
molecule, VR-RNA [72]. In two separate necrotic enteritis derived C. perfringens strains, mutation of 
the virR gene greatly reduced the production of NetB toxin [71]. This effect was reversed when the 
virR  mutants  were  complemented  with  the  wild-type  virR  gene.  VirR  acts  on  its  target  genes  by 
binding to two directly repeated sequences, or VirR boxes, that are located immediately upstream of 
the promoter. Similar repeats are located upstream of the putative netB promoter. These VirR boxes 
were shown to  be functional in  a  C. perfringens-based bioassay and  in  vitro studies  showed that 
purified VirR protein could bind to the netB-associated VirR boxes. Other workers have shown that in 
strain 13 the VirSR system appears to be regulated by an Agr-dependent quorum sensing system that 
leads to the controlled expression of specific genes in response to changes in cell density [73]. These 
findings suggest that in the gastrointestinal tract of infected birds the production of NetB is activated 
when the C. perfringens population reaches a threshold level as a result of predisposing factors, as 
reviewed previously [17,74], and nutrients start to become rate-limiting for growth.  
Any differences in necrotic enteritis disease progression could potentially be explained by sequence 
differences in  the  NetB proteins  produced  by  different strains.  To  examine the variation of NetB Toxins 2010, 2  
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proteins, the nucleotide sequence of the netB gene from a range of isolates was determined [66]. The 
poultry  isolates  examined  were  from  various  geographical  locations  including  Australia,  Belgium, 
Denmark and Canada. The netB gene and its promoter region displayed very little sequence variation; 
most of these strains had virtually identical nucleotide sequences in this region. Within the netB coding 
sequence there was only one amino acid change, A168T, which was observed in six strains. Biological 
analysis of the NetBA168T derivative showed that it was as active as the wild-type NetB protein and that 
strains  carrying  the  variant  sequence  produced  similar  levels  and  types  of  disease  when  used  in 
infection studies. The observation that NetB is very well conserved was supported by a separate study 
[68], which found that most of the 27 netB positive isolates examined contained wild-type coding and 
promoter  regions.  The  only  amino  acid  sequence  changes  observed  were  NetBA168T,  the  variant 
previously reported, and a single example of a novel variant, NetBA166V.  
5. NetB and the Development of a Necrotic Enteritis Vaccine 
Since NetB is essential for disease pathogenesis, and is a secreted toxin that should be readily 
accessible to the host immune system, it has considerable potential for vaccine development  [23]. 
Vaccines against C. perfringens or its toxins have been successfully used to prevent enteric diseases in 
various mammalian species, including humans [75–77]. Vaccine development for necrotic enteritis in 
chickens has previously focused on  -toxin, but the experimental vaccines produced have not provided 
the level of vaccine efficacy seen with clostridial vaccines in other animal species, presumably because 
ʱ-toxin  is  not  essential  for  virulence.  It  has  been  shown  that  chicken  flocks  with  high  levels  of 
maternal antibodies against  -toxin have lower mortality levels than flocks with lower titers [78]. 
Vaccines based on C. perfringens type A and C have been experimentally tested [79]. Layer hens 
vaccinated with these toxoids had high levels of anti- -toxin antibodies in their progeny compared to 
unvaccinated  hens.  Both  toxoid  vaccines  showed  levels  of  protection  against  subclinical  necrotic 
enteritis, with the type C toxoid vaccine giving higher levels of protection than the type A toxoid.  
-toxin has also been delivered as a subunit vaccine and by live delivery in Salmonella vectors, where 
it has been shown to provide some protection [80–82]. Recently, a commercial vaccine (NETVAX®, 
Schering-Plough) has been developed based on a C. perfringens type A toxoid. However, the NetB 
status of the organisms used to develop this vaccine is not known.  
Other studies aimed at the development of a necrotic enteritis vaccine have been reported. Analysis 
of  serum  from  birds  infected  with  virulent  C.  perfringens  isolates  identified
 several
 immunogenic 
secreted proteins [80]. These proteins included  -toxin, glyceraldehyde-3-phosphate dehydrogenase, 
pyruvate:ferredoxin  oxidoreductase,  fructose  1,6-biphosphate  aldolase,  and
  a  hypothetical  protein. 
These  proteins  significantly  protected  broiler  chickens
  against  a  relatively  mild  challenge,  with  
-toxin, pyruvate:ferredoxin
 oxidoreductase and the hypothetical protein offering protection against a 
more severe challenge [81]. This study provided the first evidence that a subunit vaccine could be 
useful in controlling necrotic enteritis in chickens. Of interest is that the chicken serum did not react 
strongly with NetB; possibly because NetB is not highly immunogenic in chickens or the levels of 
NetB produced in vivo are not high enough to promote reliable immune recognition.  
There are no reports in the literature addressing the use of NetB in vaccine formulations, although 
there  are  reports  of  related  proteins  from  other  bacteria  being  successfully  used  in  experimental Toxins 2010, 2  
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vaccines.  For  example,  vaccine-based  targeting  of  S.  aureus  -toxin  provided  protection  against 
staphylococcal pneumonia [83,84]. In a murine model system, monoclonal antibody-based
 therapy was 
efficacious for prevention
 and treatment of this disease [84]. Two
 distinct anti- -toxin monoclonal 
antibodies  that  block
  toxin  activity  prevented  human  lung  cell  injury  in  vitro  and
  protected 
experimental animals against lethal S. aureus pneumonia.
 Active immunization with the first
 50 amino 
acids of  -toxin also conferred protection against
 S. aureus pneumonia. This study revealed that both 
passive  and
 active  immunization  strategies  for  prevention  or  therapy  of
 staphylococcal  pneumonia 
were feasible; similar approaches could be attempted using NetB to protect against necrotic enteritis. A 
genetically toxoided version of S. aureus  -toxin, which was produced by site-directed mutagenesis, 
has  been  shown  to  generate  an  antigen-specific  immunoglobulin  G  response  and  to  be  protective 
against staphylococcal  pneumonia  [83]. A similar genetically toxoided version of NetB may have 
value for necrotic enteritis vaccine design. 
6. Conclusions  
The recently identified pore-forming toxin NetB is a key virulence determinant in C. perfringens 
strains that cause necrotic enteritis in chickens. The dimensions of the pore formed by the toxin have 
been estimated, but the determination of its exact structure and its comparison to other pore-forming 
toxins  awaits  crystallization studies.  The toxin is  produced by most strains  isolated from  necrotic 
lesions, but is less commonly found in C. perfringens isolates from healthy birds. As with many of the 
toxins  encoded  by  C.  perfringens,  NetB  production  is  regulated  by  the  VirSR  two-component 
regulatory  system,  potentially  by  a  quorum  sensing-dependent  mechanism.  NetB  is  cytotoxic  to 
chicken LMH cells but not to several other chicken cell lines or Vero cells. Further studies aimed at 
determining its cellular specificity and identifying its receptor should help to elucidate the precise role 
that NetB plays in disease pathogenesis. Since NetB is involved in virulence, and is a secreted protein 
that  should  be  readily  accessible  to  the  host  immune  system,  it  represents  a  promising  target  for 
vaccine development. Our growing knowledge of the importance and function of NetB may also lead 
to the development of useful therapeutic agents and biomarkers. The discovery that netB is part of a 
predicted  pathogenicity  locus  that  encodes  other  potential  virulence  factors  indicates  that  further 
research is required to further elucidate the mechanism of pathogenesis of this important disease.  
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